SciNeuro Pharmaceuticals
St. Louis, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $53M
Overview
A neuroscience biotech developing novel therapies for neurodegenerative and psychiatric diseases.
Neuroscience
Technology Platform
A discovery platform leveraging insights into CNS biology to identify and validate novel therapeutic targets for brain disorders.
Funding History
1Total raised:$53M
PIPE$53M
Opportunities
Success in any major CNS indication represents a blockbuster opportunity due to large patient populations and unmet need.
Risk Factors
Extreme clinical and regulatory risk inherent in CNS drug development, including difficult trial endpoints and high placebo responses.
Competitive Landscape
Faces intense competition from large pharma and other biotechs in the high-risk, high-reward neuroscience therapeutic area.